missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ HAPLN2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA561089
This item is not returnable.
View return policy
Description
Immunogen sequence: DPASHPGPHY LLPPIHEVIH SHRGATATLP CVLGTTPPSY KVRWSKVEPG ELRETLILIT NGLH Highest antigen sequence identity to the following orthologs: Mouse - 94%, Rat - 94%.
BRAL1 is a member a superfamily consisting of several highly homologous hyaluronan and proteoglycan binding link proteins. BRAL1 is predominantly expressed in brain tissue and spinal cord. Like other members in the link-module superfamily, BRAL1 contains an immunoglobulin-like fold and two proteoglycan tandem repeats (PTRs). Its mRNA expression pattern is similar to other lectican proteoglycans, suggesting that BRAL1 may act to stabilize the binding between the extracellular matrix molecule hyaluronan and brevican. Immunostaining of mouse brain showed BRAL1 expression at P20 in the white matter of the developing cerebellum and in myelinated fiber tracts in the adult brain, suggesting that expression starts when axonal myelination occurs.
Specifications
| HAPLN2 | |
| Polyclonal | |
| Unconjugated | |
| HAPLN2 | |
| 4930401E20Rik; Brain link protein 1; brain link protein-1; Bral1; HAPLN2; Hyaluronan and proteoglycan link protein 2; RP11-284F21.6 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 60484 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.05 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q9GZV7 | |
| HAPLN2 | |
| Recombinant protein corresponding to Human HAPLN2. Recombinant protein control fragment (Product #RP-94196). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction